The latest episode of “The Readout LOUD” discusses the impact of less regulation by the FDA on the biotech industry, the challenges faced by vaccine makers like Pfizer, and the potential effects of the “Make America Healthy Again” movement on the obesity drug market. Guests Lizzy Lawrence, Brian Skorney, and Daphne Zohar provide insights into how the election results could impact biopharma. To learn more about the implications of Trump’s second term for the FDA, key figures in the MAHA movement, and reactions from biopharma industry leaders post-election, listeners can tune in to the podcast on Apple Podcasts, Spotify, TuneIn, or other platforms.
Source link
How Trump’s presidency could affect biotech, FDA regulation, and more
